| Mulrooney DA et al. 2013 [98]
|
Excluded |
Pilot study of vascular health in survivors of osteosarcoma |
| Nakamura T et al. 2013 [5]
|
Included |
Determine whether circulating CRP predicts survival in bone sarcoma |
| Peng TI et al. 2012 [99]
|
Excluded |
Osteosarcoma 143B cells were utilized for study of mitochondrial dynamics |
| Fujiwara T et al. 2011 [100]
|
Excluded |
A study of macrophage infiltration in prediction of human ewing sarcoma |
| Funovics PT et al. 2011 [22]
|
Included |
A study of CRP as independent prognostic factor for survival in osteosarcoma patients |
| Jansson AF et al.2009 [101]
|
Excluded |
A study of clinical score for nonbacterial osteitis in patients |
| Schwinger W et al. 2005 [102]
|
Excluded |
A study of effect of interleukin-2 treatment in pretreated solid tumor patients including osteosarcoma |
| Patino WD et al. 2005 [103]
|
Excluded |
A study of biomarkers such as osteosarcoma (FOS) gene in atherosclerosis |
| Das T et al. 2003 [97]
|
Excluded |
A study of glycosylation in human CRP under different pathological conditions |
| Trapani S et al. 2000 [104]
|
Excluded |
A study of incidence of occult cancer in children presenting with musculoskeletal symptoms |
| Kleinerman ES et al. 1995 [105]
|
Excluded |
A study of combined therapy on patients with relapsed osteosarcoma |
| Asano T et al. 1993 [106]
|
Excluded |
A study of a novel biologic agent for osteosarcoma therapy |
| Kleinerman ES et al. 1992 [107]
|
Excluded |
Phase II study of liposomal muramyl tripeptide in osteosarcoma |
